Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in drug ...

AI could review data sets to assist clinical scientists ...

DUBLIN--(BUSINESS WIRE)--The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course 24" conference has been added to ResearchAndMarkets.com's offering.

When pharmaceutical companies develop a novel drug for the market, several steps are required to assess and regulate its safety, effectiveness, manufacturability, and reliability. These processes, and ...

Explore the role of BD&L in R&D decision-making. Understand its impact on funding and market intelligence for scientists.

Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries including Bristol-Myers Squibb, Celgene Corporation, Aurinia Pharmaceuticals, Abbvie, Nanomedicine Innovation Center.

Identifying and accelerating drug development is big business. The costs in this industry are significant and finding pathways to optimize using AI methods is top of mind in this fast and evolving ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...